FTSE Heads Lower Despite Pfizer Vaccine Approval
Despite a record setting performance on Wall Street, which saw both the S&P 500 and the Nasdaq close at record highs, EU stocks are pointing to a softer start this morning tracking mixed sentiment in Asia.
Share this:
Despite a record setting performance on Wall Street, which saw both the S&P 500 and the Nasdaq close at record highs, EU stocks are pointing to a softer start this morning tracking mixed sentiment in Asia.
Sentiment got a boost in the US session on Tuesday amid renewed hopes for additional US fiscal stimulus after a group of lawmakers unveiled $908 billion covid rescue plan. However, the rejection of the plan by Majority leader Mitch McConnell took the wind out of the rally’s sails and US futures moved lower after the close. The market has been patiently waiting for more US fiscal stimulus and for now it looks like that wait will continue.
Comment from Joe Biden that he will not undo the Phase 1 trade deal with China has also dragged on market enthusiasm. His comments suggest that it could take some time for relations to normalise.
Vaccine approval
Despite the weaker start, good news was still aplenty after the UK approved the Pfizer covid vaccine meaning that the rollout of the jab will begin next week. Vaccine developments have been the driving force behind November’s stellar performance given that a covid vaccine is the surest and quickest route to returning to pre-pandemic growth levels.
Despite the weaker start, good news was still aplenty after the UK approved the Pfizer covid vaccine meaning that the rollout of the jab will begin next week. Vaccine developments have been the driving force behind November’s stellar performance given that a covid vaccine is the surest and quickest route to returning to pre-pandemic growth levels.
German retail sales
German retail sales figures were another plus point as sales jumped a forecast beating 2.6% MoM after an upwardly revised drop of -1.9% in September. The surge in sales came ahead of Germany’s November national lockdown and following solid manufacturing PMI data in the previous session.
The EUR continues its relentless charge higher after breaking out above $1.20.
German retail sales figures were another plus point as sales jumped a forecast beating 2.6% MoM after an upwardly revised drop of -1.9% in September. The surge in sales came ahead of Germany’s November national lockdown and following solid manufacturing PMI data in the previous session.
The EUR continues its relentless charge higher after breaking out above $1.20.
ADP payroll data
Looking ahead attention will be on US ADP private payroll data. Expectations are for 475k private jobs added in November compared to 365k added in October. A strong number would bode well for Friday’s non-farm payroll report.
Looking ahead attention will be on US ADP private payroll data. Expectations are for 475k private jobs added in November compared to 365k added in October. A strong number would bode well for Friday’s non-farm payroll report.
FTSE Chart
The FTSE continues to consolidate in a horizontal channel between 6250 and 6500 which has held since early November, following the vaccine rally. The FTSE currently trades slap in the middle of the channel. Its currently testing its 50 sma on 4 hour chart at 6375. A break through here could see the 100 sma tested at 6350 prior to a deeper selloff towards 6250.
Should the 50 sma hold, a move higher back towards 6500 could be on the cards.
Despite a record setting performance on Wall Street, which saw both the S&P 500 and the Nasdaq close at record highs, EU stocks are pointing to a softer start this morning tracking mixed sentiment in Asia.
Sentiment got a boost in the US session on Tuesday amid renewed hopes for additional US fiscal stimulus after a group of lawmakers unveiled $908 billion covid rescue plan. However, the rejection of the plan by Majority leader Mitch McConnell took the wind out of the rally’s sails and US futures moved lower after the close. The market has been patiently waiting for more US fiscal stimulus and for now it looks like that wait will continue.
Comment from Joe Biden that he will not undo the Phase 1 trade deal with China has also dragged on market enthusiasm. His comments suggest that it could take some time for relations to normalise.
Vaccine approval
Despite the weaker start, good news was still aplenty after the UK approved the Pfizer covid vaccine meaning that the rollout of the jab will begin next week. Vaccine developments have been the driving force behind November’s stellar performance given that a covid vaccine is the surest and quickest route to returning to pre-pandemic growth levels.
Despite the weaker start, good news was still aplenty after the UK approved the Pfizer covid vaccine meaning that the rollout of the jab will begin next week. Vaccine developments have been the driving force behind November’s stellar performance given that a covid vaccine is the surest and quickest route to returning to pre-pandemic growth levels.
German retail sales
German retail sales figures were another plus point as sales jumped a forecast beating 2.6% MoM after an upwardly revised drop of -1.9% in September. The surge in sales came ahead of Germany’s November national lockdown and following solid manufacturing PMI data in the previous session.
The EUR continues its relentless charge higher after breaking out above $1.20.
German retail sales figures were another plus point as sales jumped a forecast beating 2.6% MoM after an upwardly revised drop of -1.9% in September. The surge in sales came ahead of Germany’s November national lockdown and following solid manufacturing PMI data in the previous session.
The EUR continues its relentless charge higher after breaking out above $1.20.
ADP payroll data
Looking ahead attention will be on US ADP private payroll data. Expectations are for 475k private jobs added in November compared to 365k added in October. A strong number would bode well for Friday’s non-farm payroll report.
Looking ahead attention will be on US ADP private payroll data. Expectations are for 475k private jobs added in November compared to 365k added in October. A strong number would bode well for Friday’s non-farm payroll report.
FTSE Chart
The FTSE continues to consolidate in a horizontal channel between 6250 and 6500 which has held since early November, following the vaccine rally. The FTSE currently trades slap in the middle of the channel. Its currently testing its 50 sma on 4 hour chart at 6375. A break through here could see the 100 sma tested at 6350 prior to a deeper selloff towards 6250.
Should the 50 sma hold, a move higher back towards 6500 could be on the cards.
Related tags:
Latest market news
The complete CFD trading experience
Award-winning platforms, competitive spreads, low commissions and dedicated support.
We live and breathe the markets and are dedicated to helping traders realise their ambitions as we continue to set the industry bar.
Economic calendar
Web Trader platform
Our sophisticated web-based platform is packed with features.
Related articles
EUR/USD, FTSE 100 Forecast: Two trades to watch 1507
EUR/USD rises after weaker US CPI, PPI up next. FTSE 100 falls as weak China GDP data hits miners.
FTSE 100, USD/JPY Forecast: Two trades to watch
FTSE eases modestly despite inflation unexpectedly holding steady. USD/JPY drifts lower ahead of the FOMC rate decision.
EUR/USD, FTSE 100 Forecast: Two trades to watch 21-05-26
EUR/USD slips below 1.16 as weak eurozone data weighs on sentiment. FTSE 100 slips as oil prices rebound and caution returns.
StoneX Europe Ltd may make third party material available on this website which may contain information included but not limited to the conditions of financial markets. The material is for information purposes only and does not contain, and should not be construed as containing, investment advice and/or investment recommendation and/or an investment research and/or an offer of or solicitation for any transactions in financial instruments; any decision to enter into a specific transaction shall be made by the client following an assessment by him/her of their situation.
StoneX Europe Ltd makes no representation or warranty and assumes no liability as to the accuracy or completeness of the information provided, nor any loss arising from any investment based on a recommendation, forecast or other information supplied. You should always seek independent advice as to your suitability to speculate in any related markets and your ability to assume the associated risks, if you are at all unsure. We are not under any obligation to update any such material. Any opinion made may be personal to the author and may not reflect the opinion of StoneX Europe Ltd.